NAD refers eFoodSafety to FTC
This article was originally published in The Tan Sheet
The National Advertising Division refers eFoodSafety.com to the Federal Trade Commission for possible law enforcement action for Internet advertising claims the firm made about its Cinnergen dietary supplement. As part of its routine monitoring program, NAD targeted Cinnergen for health-related establishment and performance claims including: "clinically proven to control blood sugar" and "over half the patients in our clinical study were able to stop taking prescribed medication!" according to a Feb. 7 decision. The Council of Better Business Bureaus group's numerous attempts to contact eFoodSafety were unsuccessful, NAD says...
You may also be interested in...
Implying that eFoodSafety.com's glucose-metabolism supplement Cinnergen is a replacement for normal insulin regimens is misleading, the National Advertising Division says
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.